Suppr超能文献

人视网膜色素上皮细胞中的凋亡介导受体-配体系统。

Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.

作者信息

Hueber Arno, Aduckathil Sanjay, Kociok Norbert, Welsandt Gerhard, Dinslage Sven, Kirchhof Bernd, Esser Peter J

机构信息

Department of Vitreo-Retinal Surgery, Center of Ophthalmology, University of Cologne, Joseph-Stelzmann-Strasse 9, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):551-6. doi: 10.1007/s00417-002-0487-6. Epub 2002 Jun 20.

Abstract

BACKGROUND

To establish new strategies for the treatment of proliferative vitreoretinopathy (PVR), we investigated new members of a recently discovered apoptosis-inducing receptor-ligand system in human retinal pigment epithelial (RPE) cells. TRAIL (Apo2-L) and Apo3-L are capable of inducing cell death via their receptors Trail-R1 to Trail-R4 and TRAMP. The goal of this study was to prove the existence of these new apoptosis-inducing receptors and ligands in RPE cells.

METHODS

Human RPE cells, cultured or prepared directly from the eye, were examined by RT-PCR. Immunohistochemistry of epiretinal membranes of traumatic PVR was performed for the detection of TRAIL and Trail-R1. Protein expression of Trail-R1 was examined in cultured human RPE cells by western blot. Cell death after TRAIL treatment of human RPE cells was measured by crystal violet staining.

RESULTS

For RPE cells derived directly from the eye, we detected mRNAs of Trail-R2, Trail-R3, TRAIL, and APO3-L, but not Trail-R1, Trail-R4, and TRAMP. All the examined transcripts were detected in human P0 RPE cells in vitro. Immunohistochemical studies on PVR membranes identified TRAIL and Trail-R1. Western blot confirmed the presence of Trail-R1 in cultured human RPE cells. TRAIL failed to kill RPE cells in vitro, but showed a strong synergistic killing effect when coincubated with protein (cycloheximide) or RNA (actinomycin D) synthesis inhibitor.

CONCLUSIONS

We detected a novel apoptosis-inducing receptor-ligand system in RPE cells. An induction of apoptosis as a treatment of PVR seems to be possible. Further investigations are needed including an animal model of PVR.

摘要

背景

为了建立增殖性玻璃体视网膜病变(PVR)的新治疗策略,我们研究了人类视网膜色素上皮(RPE)细胞中最近发现的凋亡诱导受体 - 配体系统的新成员。肿瘤坏死因子相关凋亡诱导配体(TRAIL,Apo2 - L)和Apo3 - L能够通过其受体Trail - R1至Trail - R4和TRAMP诱导细胞死亡。本研究的目的是证明这些新的凋亡诱导受体和配体在RPE细胞中的存在。

方法

通过逆转录聚合酶链反应(RT - PCR)检测培养的或直接从眼中获取的人RPE细胞。对创伤性PVR的视网膜前膜进行免疫组织化学检测,以检测TRAIL和Trail - R1。通过蛋白质印迹法检测培养的人RPE细胞中Trail - R1的蛋白表达。用结晶紫染色法测定TRAIL处理人RPE细胞后的细胞死亡情况。

结果

对于直接从眼中获取的RPE细胞,我们检测到了Trail - R2、Trail - R3、TRAIL和APO3 - L的信使核糖核酸(mRNA),但未检测到Trail - R1、Trail - R4和TRAMP的mRNA。在体外培养的人P0 RPE细胞中检测到了所有检测的转录本。对PVR膜的免疫组织化学研究鉴定出了TRAIL和Trail - R1。蛋白质印迹法证实了培养的人RPE细胞中存在Trail - R1。TRAIL在体外未能杀死RPE细胞,但与蛋白质(放线菌酮)或RNA(放线菌素D)合成抑制剂共同孵育时显示出强烈的协同杀伤作用。

结论

我们在RPE细胞中检测到了一种新的凋亡诱导受体 - 配体系统。诱导凋亡作为PVR的一种治疗方法似乎是可行的。需要进一步的研究,包括PVR动物模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验